ID27276A - Oksazolidinon-oksazolidinon untuk merawat infeksi-infeksi mata - Google Patents
Oksazolidinon-oksazolidinon untuk merawat infeksi-infeksi mataInfo
- Publication number
- ID27276A ID27276A IDW20002687A ID20002687A ID27276A ID 27276 A ID27276 A ID 27276A ID W20002687 A IDW20002687 A ID W20002687A ID 20002687 A ID20002687 A ID 20002687A ID 27276 A ID27276 A ID 27276A
- Authority
- ID
- Indonesia
- Prior art keywords
- treatment
- oksazolidinons
- infections
- eyes
- oxazolidinone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9276598P | 1998-07-14 | 1998-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID27276A true ID27276A (id) | 2001-03-22 |
Family
ID=22235050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20002687A ID27276A (id) | 1998-07-14 | 1999-07-07 | Oksazolidinon-oksazolidinon untuk merawat infeksi-infeksi mata |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US6337329B1 (ja) |
| EP (1) | EP1096934B1 (ja) |
| JP (1) | JP2002520359A (ja) |
| KR (1) | KR20010079530A (ja) |
| CN (1) | CN1305374A (ja) |
| AT (1) | ATE304886T1 (ja) |
| AU (1) | AU740781B2 (ja) |
| BG (1) | BG64666B1 (ja) |
| BR (1) | BR9912004A (ja) |
| CA (1) | CA2334811A1 (ja) |
| DE (1) | DE69927380T2 (ja) |
| DK (1) | DK1096934T3 (ja) |
| EA (1) | EA003274B1 (ja) |
| EE (1) | EE200100026A (ja) |
| ES (1) | ES2249020T3 (ja) |
| HU (1) | HUP0102836A3 (ja) |
| ID (1) | ID27276A (ja) |
| IL (1) | IL140769A0 (ja) |
| NO (1) | NO20010202L (ja) |
| NZ (1) | NZ509375A (ja) |
| PL (1) | PL345544A1 (ja) |
| PT (1) | PT1096934E (ja) |
| SG (1) | SG125079A1 (ja) |
| SK (1) | SK20332000A3 (ja) |
| TR (1) | TR200100066T2 (ja) |
| WO (1) | WO2000003710A1 (ja) |
| ZA (1) | ZA200100038B (ja) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR020660A1 (es) * | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | Composiciones antibioticas para el tratamiento de ojos, oidos y nariz |
| WO2001019366A1 (en) * | 1999-09-13 | 2001-03-22 | Insite Vision Incorporated | Topical treatment for prevention of ocular infections |
| US6562820B2 (en) | 2000-07-05 | 2003-05-13 | Pharmacia & Upjohn Company | Method for treatment and prevention of mastitis |
| PE20020300A1 (es) * | 2000-08-22 | 2002-05-10 | Pharmacia Corp | Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco |
| AR031135A1 (es) | 2000-10-10 | 2003-09-10 | Upjohn Co | Composiciones de antibiotico topico para el tratamiento de infecciones oculares |
| US7125568B2 (en) * | 2001-08-23 | 2006-10-24 | Sung Michael T | Lipophilic drug compositions |
| US20030069235A1 (en) * | 2001-09-14 | 2003-04-10 | J. Greg Slatter | Treatment for ocular infections |
| JP2005521691A (ja) * | 2002-02-22 | 2005-07-21 | ファルマシア・コーポレーション | シクロデキストリン化合物及び塩化セチルピリジニウムを含有する眼科用抗菌性薬物製剤 |
| TW201043267A (en) * | 2009-03-19 | 2010-12-16 | Intervet Int Bv | In situ constituting a vaccine for administration to a predetermined herd of animals |
| CN101766628B (zh) * | 2010-01-20 | 2012-07-04 | 广东宏盈科技有限公司 | 一种眼科外用抗细菌感染药物 |
| CN108452316B (zh) | 2012-09-13 | 2022-04-15 | 星法马有限公司 | 眼部感染的治疗或预防方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5164510A (en) * | 1988-09-15 | 1992-11-17 | The Upjohn Company | 5'Indolinyl-5β-amidomethyloxazolidin-2-ones |
| US5231188A (en) | 1989-11-17 | 1993-07-27 | The Upjohn Company | Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents |
| EP0610265B1 (en) * | 1991-11-01 | 1996-12-27 | PHARMACIA & UPJOHN COMPANY | Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents |
| US5688792A (en) | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
| CA2174107C (en) * | 1993-11-22 | 2005-04-12 | Steven J. Brickner | Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones |
| DE4425613A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
| DE4425612A1 (de) * | 1994-07-20 | 1996-04-04 | Bayer Ag | 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone |
| PL330241A1 (en) * | 1996-05-31 | 1999-05-10 | Scripps Research Inst | Methods of and compositions useful in inhibiting angiogenesis |
-
1999
- 1999-07-07 PL PL99345544A patent/PL345544A1/xx unknown
- 1999-07-07 SG SG200300091A patent/SG125079A1/en unknown
- 1999-07-07 KR KR1020017000567A patent/KR20010079530A/ko not_active Application Discontinuation
- 1999-07-07 DK DK99933483T patent/DK1096934T3/da active
- 1999-07-07 BR BR9912004-6A patent/BR9912004A/pt not_active Application Discontinuation
- 1999-07-07 CN CN99807427A patent/CN1305374A/zh active Pending
- 1999-07-07 SK SK2033-2000A patent/SK20332000A3/sk unknown
- 1999-07-07 ES ES99933483T patent/ES2249020T3/es not_active Expired - Lifetime
- 1999-07-07 EE EEP200100026A patent/EE200100026A/xx unknown
- 1999-07-07 HU HU0102836A patent/HUP0102836A3/hu unknown
- 1999-07-07 EA EA200100133A patent/EA003274B1/ru unknown
- 1999-07-07 PT PT99933483T patent/PT1096934E/pt unknown
- 1999-07-07 WO PCT/US1999/012367 patent/WO2000003710A1/en not_active Application Discontinuation
- 1999-07-07 JP JP2000559845A patent/JP2002520359A/ja not_active Withdrawn
- 1999-07-07 ID IDW20002687A patent/ID27276A/id unknown
- 1999-07-07 AU AU49530/99A patent/AU740781B2/en not_active Ceased
- 1999-07-07 CA CA002334811A patent/CA2334811A1/en not_active Abandoned
- 1999-07-07 US US09/349,430 patent/US6337329B1/en not_active Expired - Fee Related
- 1999-07-07 DE DE69927380T patent/DE69927380T2/de not_active Expired - Fee Related
- 1999-07-07 NZ NZ509375A patent/NZ509375A/en unknown
- 1999-07-07 AT AT99933483T patent/ATE304886T1/de not_active IP Right Cessation
- 1999-07-07 IL IL14076999A patent/IL140769A0/xx unknown
- 1999-07-07 EP EP99933483A patent/EP1096934B1/en not_active Expired - Lifetime
- 1999-07-07 TR TR2001/00066T patent/TR200100066T2/xx unknown
-
2001
- 2001-01-02 ZA ZA200100038A patent/ZA200100038B/en unknown
- 2001-01-10 BG BG105142A patent/BG64666B1/bg unknown
- 2001-01-12 NO NO20010202A patent/NO20010202L/no not_active Application Discontinuation
- 2001-09-19 US US09/955,679 patent/US6740652B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60134134D1 (de) | Prophylaktische und therapeutische behandlung von ten mit verbindungen, die auf monosacchariden basieren | |
| DK0867184T3 (da) | Anvendelse af tiagabin til behandling af søvnforstyrrelser | |
| LU91928I2 (fr) | Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®) | |
| DK0880350T3 (da) | Behandling af dissemineret sklerose | |
| DE59802356D1 (de) | Lagerstabile ophthalmische zusammensetzungen, umfassend diclofenac und ofloxacin | |
| ID27276A (id) | Oksazolidinon-oksazolidinon untuk merawat infeksi-infeksi mata | |
| BR9814923A (pt) | Método para tratamento de doença de alzheimer | |
| ATE201597T1 (de) | Verabreichung von riluzol zur behandlung von neuro-aids | |
| EA200300560A1 (ru) | Улучшенный способ лечения | |
| DK52487A (da) | Ophthalmisk anvendelse af quinolon- og naphthyri- dinforbindelser | |
| CA2254682A1 (en) | Method of treating eye infections with azithromycin | |
| DK1305037T3 (da) | Smertestillende medikament | |
| SE0004101D0 (sv) | New use | |
| SE9403160D0 (sv) | Method and means for prevention and treatment of secondary cataract | |
| EA200100010A1 (ru) | Местное применение оксазолидинонов для трансдермальной доставки | |
| CA2355359A1 (fr) | Utilisation du riluzole dans le traitement des traumatismes acoustiques | |
| NO20006087L (no) | Fremgangsmåter for å öke nivåer av acetylcholin | |
| NO984198L (no) | FremgangsmÕte for behandling av aggresjon | |
| MX9604692A (es) | Derivados de quinoxalina para el tratamiento de tinnitus. | |
| NO984196D0 (no) | Fremgangsmåte for behandling av stoffmisbruk | |
| WO1999065511A3 (en) | Composition and method for treatment of pseudomonas infection |